Dudediligence.

Belite Bio, Inc

BLTENASDAQ
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$97.0M

13 notices · 589,166 sh

Oct 2025 to Oct 2026

Reported ·

$40.5M

167 sales · 0 buys

Oct 2025 to Sep 2026

The two figures cover different periods.

154 of 167 reported sales carry the 10b5-1 box. Together they are 0.56% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Sep 2026N2025DJ2026FMAMJJASO2026-10-01: Hendrik Peter Scholl, Form 1442026-08-12: Yu-Hsin Lin, Form 1442026-08-12: Hao-Yuan Chuang, Form 1442026-06-18: Dr. Hendrick P. Scholl, Form 1442026-06-16: Dr. Hendrick P. Scholl, Form 1442026-04-15: Nathan L. Mata, Form 1442026-04-09: Wan Shan Chen, Form 1442026-04-09: Yu-Hsin Lin, Form 1442026-04-09: Hao-Yuan Chuang, Form 1442025-10-17: Wan Shan Chen, Form 1442025-10-16: Wan Shan Chen, Form 1442025-10-13: Wan Shan Chen, Form 1442025-10-13: Hao-Yuan Chuang, Form 1442026-04-09: Chuang Hao-Yuan, sold2026-04-09: Chen Wan-Shan, sold2026-04-09: Lin Yu-Hsin, sold2026-04-15: MATA NATHAN L., sold2026-04-16: MATA NATHAN L., sold2026-04-17: MATA NATHAN L., sold2026-04-20: MATA NATHAN L., sold2026-04-21: MATA NATHAN L., sold2026-04-22: MATA NATHAN L., sold2026-04-23: MATA NATHAN L., sold2026-04-24: MATA NATHAN L., sold2026-04-27: MATA NATHAN L., sold2026-04-28: MATA NATHAN L., sold2026-04-29: MATA NATHAN L., sold2026-04-30: MATA NATHAN L., sold2026-05-01: MATA NATHAN L., sold2026-05-04: MATA NATHAN L., sold2026-05-05: MATA NATHAN L., sold2026-05-06: MATA NATHAN L., sold2026-05-07: MATA NATHAN L., sold2026-06-16: Scholl Hendrik Peter, sold2026-06-18: Scholl Hendrik Peter, sold2026-08-12: Lin Yu-Hsin, sold2026-08-12: Chuang Hao-Yuan, sold2026-09-04: Chuang Hao-Yuan, sold2026-09-04: Lin Yu-Hsin, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-10-01Hendrik Peter Scholl, Chief Medical Officer$679,280
4,000 shplan 2026-06-25Form 4s on file end Sep 23144 ↗
2026-08-12Yu-Hsin Lin, Chief Executive Officer$22.5M
126,800 shplan 2025-12-23144 ↗
Form 4, 2026-08-14: sold 365 at $180.35 Form 4 ↗
2026-08-12Hao-Yuan Chuang, Chief Financial Officer$16.7M
93,800 shplan 2025-12-22144 ↗
Form 4, 2026-08-14: sold 367 at $180.35 Form 4 ↗
2026-06-18Dr. Hendrick P. Scholl, Chief Medical Officer$1,483,400
10,000 shno plan date144 ↗
Form 4, 2026-06-22: sold 10,000 at $145.24 Form 4 ↗
2026-06-16Dr. Hendrick P. Scholl, Chief Medical Officer$1,442,400
10,000 shno plan date144 ↗
Form 4, 2026-06-17: sold 10,000 at $140.57 Form 4 ↗
2026-04-15Nathan L. Mata, Chief Scientific Officer$2,865,385
16,666 shplan 2025-12-10144 ↗
Form 4, 2026-04-16: sold 1,000 at $168.30 Form 4 ↗
2026-04-09Wan Shan Chen, affiliate$2,220,250
10,196 sh10b5-1 plan144 ↗
Form 4, 2026-04-13: sold 1,100 at $180.43 Form 4 ↗
2026-04-09Yu-Hsin Lin, Chief Executive Officer$24.3M
136,000 shplan 2025-12-23144 ↗
Form 4, 2026-04-13: sold 9,200 at $181.45 Form 4 ↗
2026-04-09Hao-Yuan Chuang, Chief Financial Officer$17.9M
100,000 shplan 2025-12-22144 ↗
Form 4, 2026-04-13: sold 6,200 at $181.50 Form 4 ↗
2025-10-17Wan Shan Chen, Affiliate$1,164,500
9,550 shno plan dateno Form 4 on file144 ↗
2025-10-16Wan Shan Chen, affiliate$89,250
1,050 shno plan dateno Form 4 on file144 ↗
2025-10-13Wan Shan Chen, affiliate$84,000
1,050 shplan 2024-12-13no Form 4 on file144 ↗
2025-10-13Hao-Yuan Chuang, Chief Financial Officer$5,588,208
70,054 shplan 2025-03-20no Form 4 on file144 ↗